SB Life Science Equity Management is a venture capital firm that is dedicated to funding and building successful businesses in health care.
SB Life Science Equity Management is a venture capital firm that is dedicated to funding and building successful businesses in health care. Their team of professionals has experience in venture capital, management consulting and cross-border business development with Asia.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 17, 2021
EQRx
|
Post-IPO Equity | $1.20B | Biotechnology | Yes |
Jul 3, 2008
Gemin X Pharmaceuticals
|
Series C | $38M | Biotechnology | — |
Apr 23, 2007
CircuLite
|
Series B | $5M | Health Care | — |
Jan 6, 2006
Perlegen Sciences
|
Series D | $50M | Biotechnology | — |
Dec 14, 2005
Optimer Pharmaceuticals
|
Series D | $22.20M | Biotechnology | — |
SB Life Science has had 4 exits. SB Life Science most notable exits include EQRx , CircuLite
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Dec 17, 2021 | EQRx | IPO | Biotechnology | Detail |
Dec 2, 2013 | CircuLite | M&A | Health Care | Detail |
Mar 21, 2011 | Gemin X Pharmaceuticals | M&A | Biotechnology | Detail |
Feb 16, 2007 | Optimer Pharmaceuticals | M&A | Biotechnology | Detail |